A Stress Testing Study of Glimepiride Drug Substance Utilizing UPLC/MS Methodology

Significance of the Topic

Forced degradation studies are essential in analytical chemistry to characterize the stability profile of drug substances. They identify likely degradation products, establish degradation pathways, and demonstrate method specificity for stability-indicating assays. By applying UPLC/MS, researchers can detect low-level impurities with high resolution and sensitivity, supporting the development of safe, effective pharmaceuticals.

Objectives and Study Overview

This study aimed to evaluate the forced degradation behavior of glimepiride under acidic, alkaline, oxidative, and thermal conditions. Key goals included:

• Establishing a generic UPLC method for rapid screening of degradants.
• Quantifying glimepiride decomposition kinetics.
• Utilizing single-quadrupole MS for peak purity assessment and degradant identification.

Methodology

Glimepiride was dissolved in methanol to form a 500 µg/mL stock solution. Stress conditions included 0.5 N HCl, 0.5 N NaOH, 4% H₂O₂, and elevated temperature (90 °C). Samples were taken at 0, 30, 60, 90, 120, and 180 minutes, diluted to 125 µg/mL, and analyzed by UPLC/MS.

Chromatographic conditions:

• Column: 2.1 × 50 mm, 1.7 µm C18 at 30 °C
• Mobile phases: 20 mM ammonium formate (pH 3.0) and acetonitrile
• Gradient: 5–95% B over 5 min at 0.8 mL/min

MS settings:

• Single-quadrupole detector, ESI positive mode
• Capillary voltage 3200 V, cone 20 V
• Desolvation at 500 °C with 1200 L/h gas flow
• Scan range 100–600 m/z

Instrumentation Used

• Waters ACQUITY UPLC system
• ACQUITY UPLC BEH C18 column
• Waters ACQUITY SQ Detector (single quadrupole MS)
• Empower 2 chromatography data system

Main Results and Discussion

System suitability demonstrated area RSD of 0.9% and retention time RSD of 0.0%. Linearity over 25–250 µg/mL yielded R² = 0.99982. Kinetic analysis showed first-order rates: acidic (1.1×10⁻³ min⁻¹), oxidative (1.2×10⁻³ min⁻¹), thermal (2.9×10⁻³ min⁻¹), and alkaline (4.3×10⁻³ min⁻¹), ranking susceptibility acid < oxidative < thermal < alkaline.

Chromatograms revealed six major degradant peaks (A–F). MS data enabled mass assignment and detection of co-elution (notably peak B with m/z 352, 390, 561). The approach confirmed degradant identity and peak purity, illustrating the benefit of coupling UPLC separation with MS detection.

Benefits and Practical Applications

The generic UPLC/MS method offers fast, high-resolution screening of degradation products. Single-quadrupole MS provides rapid mass confirmation and purity assessment. Results guide selection of diluents, sample preparation, and final method conditions for formulation development and stability studies.

Future Trends and Potential Applications

Emerging directions include:

• Integration of high-resolution MS for accurate mass determination of unknown degradants.
• Automated data processing and chemometric tools for degradation pathway elucidation.
• Predictive stability modeling using machine learning.
• Real-time monitoring of drug stability in formulation matrices.

Conclusion

A generic UPLC method coupled with single-quadrupole MS and Empower 2 software successfully characterized glimepiride degradation under multiple stress conditions. The workflow delivered rapid, sensitive detection of impurities, informing further method development and ensuring robust stability-indicating assays.

References

• Jones MD, Wheaton J, Wojtusik MJ, Plumb RS. A Stress Testing Study of Glimepiride Drug Substance Utilizing UPLC/MS Methodology. Waters Corporation; 2008.